SG Americas Securities’s Xilinx Inc XLNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-20,000
Closed -$1K 3655
2021
Q4
$1K Sell
20,000
-120,000
-86% -$23.7M ﹤0.01% 3329
2021
Q3
$676K Buy
140,000
+120,000
+600% +$17.6M ﹤0.01% 2252
2021
Q2
$28K Hold
20,000
﹤0.01% 2768
2021
Q1
$45K Sell
20,000
-19,400
-49% -$2.59M ﹤0.01% 3171
2020
Q4
$101K Buy
39,400
+19,400
+97% +$2.52M ﹤0.01% 3042
2020
Q3
$121K Sell
20,000
-210,000
-91% -$21.6M ﹤0.01% 2382
2020
Q2
$473K Sell
230,000
-145,000
-39% -$12.9M ﹤0.01% 2141
2020
Q1
$3.74M Buy
375,000
+350,000
+1,400% +$30.5M 0.04% 497
2019
Q4
$89K Buy
+25,000
New +$2.35M ﹤0.01% 2982
2019
Q2
Sell
-21,200
Closed -$32K 3558
2019
Q1
$32K Buy
+21,200
New +$2.38M ﹤0.01% 3247
2016
Q1
Sell
-50,000
Closed -$1K 3330
2015
Q4
$1K Buy
+50,000
New +$2.36M ﹤0.01% 2676
2015
Q3
Sell
-50,000
Closed -$122K 2834
2015
Q2
$122K Hold
50,000
﹤0.01% 2252
2015
Q1
$200K Sell
50,000
-78,200
-61% -$3.21M ﹤0.01% 1878
2014
Q4
$288K Buy
128,200
+64,000
+100% +$2.77M ﹤0.01% 2113
2014
Q3
$285K Buy
+64,200
New +$2.8M ﹤0.01% 1790

Other funds holding XLNX

SG Americas Securities's XLNX Position: Q1 2022 in Review

SG Americas Securities sold out of Xilinx Inc (XLNX) in Q1 2022, closing a stake of 461,234 shares — an estimated $97.8M sold.

SG Americas Securities first reported a position in XLNX in Q2 2013 and held it in 35 quarters. The position peaked at $97.8M in Q4 2021. 4 funds tracked by Wall St. Rank hold XLNX as of Q1 2022.

  • SG Americas Securities reported no remaining Xilinx Inc position as of Q1 2022 after selling out during the quarter.
  • SG Americas Securities sold 461,234 Xilinx Inc shares in Q1 2022, an estimated $97.8M.
  • SG Americas Securities first reported a position in Xilinx Inc in Q2 2013 and held it in 35 quarters.
  • SG Americas Securities's Xilinx Inc position peaked at $97.8M in Q4 2021.
  • 4 funds tracked by Wall St. Rank held Xilinx Inc as of Q1 2022.

Based on SG Americas Securities's 13F filing for Q1 2022, filed 29 Apr 2022.